ARNASA

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Study Name:
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Targeted Disease(s):
COPD

Purpose of Study:

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current smokers and have a history of frequent exacerbations.

Study Dates:
December 1, 2022 - June 30, 2025

Type of Study:
Pre-Market

Study Design:
Controlled Design

Study Location:
Nationwide

Lead Institution:
Synexus Clinical Research

Sponsors:

Hoffman-La Roche

ClinicalTrails.gov Identifier:
NCT05595642

Register for Trial
Asthma Basics Workshop - National
, | Apr 17, 2024
Asthma Basics Workshop - National
, | May 07, 2024